Type 1 diabetes and the microbiota: MAIT cells as biomarkers and new therapeutic targets

Scientists have discovered that the onset of type 1 diabetes is preceded by modification of MAIT lymphocytes. These cells—associated with mucosae and able to recognize elements of the microbiota—could therefore serve as new biomarkers for early detection and prevention of the illness.